Clinical Trial Update: Low-dose Buprenorphine Initiation for Opioid Use Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial is studying low-dose buprenorphine initiation for Opioid Use Disorder, sponsored by Montefiore Medical Center, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Opioid Use Disorder | Phase 4 | Status: RECRUITING